U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06911424) titled 'Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis' on March 19.
Brief Summary: The purpose of this clinical trial is to demonstrate the superiority of fusidic acid 1% over placebo in adults and children with confirmed bacterial conjunctivitis and to further establish the safety profile of fusidic acid 1% for topical ocular administration.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Bacterial Conjunctivitis
Intervention:
DRUG: Fusidic Acid 1%
Fusidic acid 1%
DRUG: Placebo
Placebo ophthalmic solution
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Baxis Pharmaceuticals, Inc.
Publ...